Correlation of tumor-related immunity with 18F-FDG-PET in pulmonary squamous-cell carcinoma. (May 2018)

• Record Type: Journal Article
• Authors: Kasahara, Norimitsu; Kaira, Kyoichi; Bao, Pinjie; Higuchi, Tetsuya; Arisaka, Yukiko; Erkhem-Ochir, Bilguun; Sunaga, Noriaki; Ohtaki, Yoichi; Yajima, Toshiki; Kosaka, Takayuki; Oyama, Tetsunari; Yokobori, Takehiko; Asao, Takayuki; Nishiyama, Masahiko; Tsushima, Yoshito; Kuwano, Hiroyuki; Shimizu, Kimihiro; Mogi, Akira
• Is Part Of: Lung cancer. Volume 119(2018)
• Page Start: 71
• Page End: 77
• Publication Date: 2018-05
• Subjects: 18F-FDG-PET 2-Deoxy-2-[fluorine-18] fluoro-d-glucose with positron emission tomography -- GLUT1 glucose transporter 1 -- HIF-1α hypoxia-inducible factor-1α -- PD-1 programmed death-1 -- SQC squamous-cell carcinoma -- TILs tumor-infiltrating lymphocytes; PD-L1 -- 18F-FDG-PET -- Lung cancer -- Squamous-cell carcinoma -- GLUT1 -- HIF-1; Lungs -- Cancer -- Periodicals; Lung Neoplasms -- Abstracts; Lung Neoplasms -- Periodicals; Poumons -- Cancer -- Périodiques; Lungs -- Cancer; Periodicals; Electronic journals; Electronic journals; 616.99424
• DOI: 10.1016/j.lungcan.2018.03.001
• Languages: English
• ISSNs: 0169-5002

Abstract

Highlights: The SUVmax of 18 F-FDG was significantly correlated with PD-L1. PD-L1 expression, and SUVmax were independent prognostic factors for OS. For patients with high SUVmax, PD-L1 was an independent prognostic factor. Abstract: Objectives: 2-Deoxy-2-[fluorine-18] fluoro-d -glucose with positron emission tomography ( 18 F-FDG-PET) is a clinically useful tool for cancer evaluation. 18 F-FDG accumulation in tumor cells is known to be correlated with the presence of glucose transporter 1 (GLUT1) and hypoxia-inducible factor-1α (HIF-1α). Although anti-programmed death-1 (PD-1) antibody treatments have been approved, no suitable predictor of significant responders has been identified. Based on the existing information, we investigated the relationship between tumor immunity (including PD-L1) and 18 F-FDG uptake in patients with surgically resected pulmonary squamous-cell carcinoma (SQC). Materials and methods: This study included 167 patients (153 men and 14 women) with SQC who underwent 18 F-FDG PET. Tumor sections were stained by immunohistochemistry for GLUT1, HIF-1α, PD-L1, CD4, CD8, and Foxp3. The relationship between clinicopathological features and 18 F-FDG uptake was analyzed. Student's t -test, the χ 2 test, non-parametric Spearman's rank test and the Kaplan–Meier method were used to show associations between variables. Results: The rate of positive PD-L1 expression was 79% (132/167), and PD-L1 expression was significantly associated with GLUT1 ( P < 0.01), HIF-1α ( P < 10 −4 ), and CD8 ( P < 1 × 10 −3 ) expression. The SUVmax of 18 F-FDG was significantly correlated with PD-L1 ( P = 0.02) and GLUT1 ( P < 0.01) expression. Multivariate analysis demonstrated that advanced stage, elevated PD-L1 expression, and elevated SUVmax were independent prognostic factors for predicting poor OS. Among patients with a high SUVmax, multivariate analysis confirmed that advanced stage and high PD-L1 expression were independent prognostic factors for poor OS; however, there was no significant difference among patients with a low SUVmax . Conclusion: High SUVmax on 18 F-FDG-PET is associated with PD-L1 expression but is an independent prognostic factor for OS in our population of surgically resected pulmonary squamous-cell carcinoma.